Omineca Announces Upsized and Fully Allocated $2.8 Million Brokered Financing of Flow-Through Units Pharmaceutical Investing
Betterlife Publishes Promising Results from a Study Titled "A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders" Pharmaceutical Investing
Bristol Myers Squibb to Report Results for First Quarter 2023 on April 27, 2023 Pharmaceutical Investing
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc. Pharmaceutical Investing
BOTOX® Cosmetic Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs Pharmaceutical Investing
Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion Pharmaceutical Investing
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure Pharmaceutical Investing
